Clinical Trial

FAK Inhibitor in Patients With Advanced Solid Tumors

Name: FAK Inhibitor in Patients With Advanced Solid Tumors — clinical trial record (NCT07596381)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is A Phase I/Ib Study，aimed to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Efficacy of Focal Adhesion Kinase Inhibitor IN10028 as Monotherapy and Combination Therapy in Patients with Advanced Solid Tumors.

Trial Details

NCT Number	NCT07596381
Lead Sponsor	InxMed (Shanghai) Co., Ltd. Collaborators: InxMed (Nanjing) Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	75 participants
Start Date	2026-05-30
Primary Completion	2027-02-28 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-05-19